Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 in the footer, replacing v3.4.1; no study data or functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T16:34:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no core study content, eligibility criteria, locations, or results appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:14:40.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    UI updates add Show glossary and Hide glossary controls and minor metadata label changes (e.g., Last Update Submitted that Met QC Criteria and Revision: v3.4.0), which do not affect the study content, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-23T05:21:40.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. This is a minor versioning update and does not affect study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-01-16T01:39:28.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.1%
    Check dated 2025-12-18T21:51:50.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. No study details or content appeared to be altered.
    Difference
    0.1%
    Check dated 2025-11-27T04:09:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.